EUVIMEDEUVIMED entdecken
Crossref

Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice

Rachel L Shapiro iD, Titania Bethiana iD, Davell M Carter iD, Jairo Ortiz iD, Kevin DeLong iD, Nicole Anders, Tricia A Numan, Eliza Duggan, Hannah C Zierden iD, Laura M Ensign iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01618-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Rachel L Shapiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD, 21218, USA. Hauptthemen laut MEDLINE: Estradiol, Atrophy, Vagina, Poloxamer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National Cancer Institute (NCI), NCATS NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaginal atrophy affects up to 57% of post-menopausal women, with symptoms ranging from vaginal burning to dysuria. Estradiol hormone replacement therapy may be prescribed to alleviate these symptoms, though many vaginal products have drawbacks including increased discharge and local tissue toxicity due to their hypertonic nature. Here, we describe the development and characterization of a Pluronic F127-coated estradiol nanosuspension (NS) formulation for improved vaginal estradiol delivery. We compare the pharmacokinetics to the clinical comparator vaginal cream (Estrace) and demonstrate increased delivery of estradiol to the vaginal tissue. We utilized ovariectomized (OVX) mice as a murine model of post-menopausal vaginal atrophy and demonstrated equivalent efficacy in vaginal re-epithelialization when dosed with either the estradiol NS or Estrace cream. Further, we demonstrate compatibility of the estradiol NS with vaginal bacteria in vitro. We demonstrate that a Pluronic F127-coated estradiol NS may be a viable option for the treatment of post-menopausal vaginal atrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstradiolAtrophyVaginaPoloxamerAnimalsFemaleAdministration, IntravaginalMiceNanoparticlesVaginal DiseasesSuspensionsMice, Inbred C57BLOvariectomyPostmenopauseVaginal Creams, Foams, and JelliesDisease Models, Animal

Stichwörter der Autor:innen

EstradiolMenopauseNanosuspensionVaginal atrophyVaginal drug delivery

Substanzen

EstradiolPoloxamerSuspensionsVaginal Creams, Foams, and Jellies

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD, 21218, USA.
  • The Center for Nanomedicine, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA.
  • Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA.
  • Department of Pathology, Sibley Memorial Hospital, Johns Hopkins University School of Medicine, Washington, DC, 20016, USA.

ORCID-Profile: Rachel L Shapiro, Titania Bethiana, Davell M Carter, Jairo Ortiz, Kevin DeLong, Hannah C Zierden, Laura M Ensign

Förderung

  • National Cancer Institute (NCI)
  • NCATS NIH HHS
  • NCRR NIH HHS
  • National Institute of Child Health and Human Development
  • National Science Foundation Graduate Research Fellowship Program
  • Hartwell Foundation
  • National Center for Advancing Translational Sciences
  • National Center for Research Resources

Zitieren

APA

Shapiro, R. L., Bethiana, T., Carter, D. M., Ortiz, J., DeLong, K., Anders, N., Numan, T. A., Duggan, E., Zierden, H. C., & Ensign, L. M. (2025). Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01618-6

Vancouver

Shapiro RL, Bethiana T, Carter DM, Ortiz J, DeLong K, Anders N, et al. Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01618-6

BibTeX
@article{Shapiro2025,
  author = {Shapiro, Rachel L and Bethiana, Titania and Carter, Davell M and Ortiz, Jairo and DeLong, Kevin and Anders, Nicole and Numan, Tricia A and Duggan, Eliza and Zierden, Hannah C and Ensign, Laura M},
  title = {Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01618-6}
}
Kostenlos starten →